MEDICAL TRIBUNAL OF NSW REASONS. Matter no: of 2012
|
|
- Penelope Nash
- 8 years ago
- Views:
Transcription
1 MEDICAL TRIBUNAL OF NSW REASONS Deputy Chairperson: Tribunal Members: Judge A. Balla Dr E Kok DrGDore Dr A Glass, PhD Matter no: of 2012 Applicant: Respondent: Counsel for the Applicant: Counsel for the Respondent: Health Care Complaints Commission Dr Zeitoun Athour Mr P Griffin Mr P Strickland, SC Judgment Date: 20 December 2013
2 PURSUANT TO CLAUSE 7 OF SCHEDULE 5D OF THE HEALTH PRACTITIONER REGULATION NATIONAL LAW (NSW) THE TRIBUNAL HAS MADE A NON PUBLICATION ORDER IN RESPECT OF ANY MATERIAL WHICH MAY IDENTIFY ANY PATIENT OR THEIR FAMILY MEMBERS III!ii Outline...2 What is rapid opioid detoxification?... 2 TheComplaint... 3 Resolving the Particulars which are denied by Dr Athour... 7 Particular I... 7 Particulars12 and Particular Particular Particulars25 and FactualFindings Risks Unsatisfactory professional conduct Professional misconduct
3 Outline Dr Athour is a general practitioner. The Complaint arises out of Dr Athour s treatment of 14 patients, who were heroin addicts, with rapid opioid detoxification. He performed the procedure in the patients homes, usually on Saturdays, with members of the patient s family attending as support persons. On one occasion he performed the procedure in a hotel room. The Tribunal is to first determine whether Dr Athour is guilty of unsatisfactory professional conduct and professional misconduct. The Tribunal s findings in relation to these issues are set out in these Reasons. The matter has been listed for further hearing on 4 March 2014 for submissions from the parties in relation to the appropriate protective Orders. What is rapid opioid detoxification? Professor Saunders, who is a highly experienced consultant physician in Internal Medicine and Addiction Medicine, defined detoxification as the process by which a person decreases his or her use of an addictive drug in a supervised manner so that the withdrawal syndrome is minimised. He described two procedures. The first type of detoxification is standard opioid detoxification. The patient ceases use of an opioid drug under supervision. The withdrawal syndrome starts 6 to 24 hours later. The symptoms increase in severity over time, usually finishing after around five days if the patient is addicted to heroin. The patient is given medication to suppress and alleviate the symptoms, which are similar to a moderate bout of the flu together with anxiety, depression and a craving for the opioid drug. While the procedure is an unpleasant experience it rarely causes severe illness and is virtually never life threatening. The second type is rapid opioid detoxification which is designed to shorten the withdrawal period to between 24 and 48 hours. An opioid antagonist is administered to precipitate the withdrawal. The symptoms are significantly more severe than those caused by the first type of detoxification. Patients can become very hypertensive and there can be profuse vomiting, diarrhoea and abdominal pain. Drugs are administered to suppress these reactions. During the procedure undertaken by Dr Athour, a Naltrexone implant was inserted through an incision into the abdomen for ongoing relapse prevention. There are well-recognised complications from rapid opioid detoxification including cerebral oedema causing acute confusion and delirium, dehydration and electrolyte disturbance. Acute
4 hospitalisation may be required for complications such as encephalopathy, cardiac arrhythmias and renal failure. There have been a number of deaths due to rapid opioid detoxification in New South Wales. The Complaint The Health Care Complaints Commission says that: Dr Athour treated the 14 patients without having adequate training, knowledge or experience. This was a breach of the NSW Medical Board s Code of Professional Conduct (the NSW Code of Conduct) and the Medical Board of Australia s Code of Conduct for Doctors in Australia (the National Code of Conduct). Dr Athour admits this Particular in relation to 13 of the patients. In relation to Patient L he disputes the date on which the rapid opioid detoxification occurred. Dr Athour admits that the treatment was a breach of the Codes of Conduct. (Particulars I and 2) Dr Athour provided rapid opioid detoxification to the patients in unlicensed premises. Dr Athour admits this Particular. (Particular 3) Dr Athour failed to ensure there was an appropriate level of care available to each of the patients in the event of a severe reaction, including: (a) access to basic resuscitation equipment; (b)the capacity to retain a patient in in-patient care overnight. This was also a breach of the NSW Health Rapid Detoxification From Opioids Guidelines (the ROD Guidelines). Dr Athour admits these Particulars. (Particulars 4 and 5) Dr Athour failed to ensure that each of the patients had been opiold free for at least 48 hours prior to initiating rapid opioid detoxification. This was also a breach of the ROD Guidelines. Dr Athour admits these Particulars. (Particulars 6 and 7) 3
5 . Dr Athour failed to undertake and/or record a detailed assessment of the drug and alcohol use history of the patients prior to undergoing the detoxification. This was also a breach of the ROD Guidelines. Dr Athour admits these Particulars. (Particulars 8 and 9). Dr Athour failed to obtain and/or record a detailed medical and psychiatric history in relation to each of the patients. This was also a breach of the ROD Guidelines. Dr Athour admits these Particulars. (Particulars 10 and 11). Dr Athour failed to adequately medically assess each of the patients for contraindications to rapid opioid detoxification including: (a) cardiac disease; (b)chronic renal impairment; (c) decompensated liver disease; (d)current dependence on benzodiazepines, alcohol or stimulants; (e)history of psychosis; This was also a breach of the ROD Guidelines. Dr Athour denies some of these Particulars. (Particulars 12 and 13). Dr Athour noted in one of the patient s records that the patient suffered from epilepsy. He provided rapid opioid detoxification without: (a) ascertaining and/or recording any information regarding recency of seizures; (b)undertaking research regarding safety of rapid opioid detoxification in epileptic patients and/or failing to record the results of such research; (c) seeking advice regarding safety of rapid opioid detoxification in epileptic patients from specialists in the area of addiction medicine and/or failing to record the results of such enquiries. Dr Athour admits this Particular. (Particular 14). Dr Athour failed to conduct or refer any of the patients for a psychological assessment prior to administering rapid opioid detoxification treatment. This breached the ROD Guidelines. 4
6 Dr Athour denies that he failed to conduct a psychological assessment of the patients prior to administering rapid opioid detoxification but admits that he did not refer any of the patients for psychological assessment and admits that his conduct was a breach of the Guidelines. (Particulars 15 and 16). Dr Athour failed to conduct or refer any of the patients for a psychosocial assessment prior to administering rapid opioid detoxification treatment to assess the following: (a)why the patient has presented for treatment; (b)the patient s level of motivation and commitment to abstinence; (c) current circumstances including employment and living circumstances; (d)social and emotional supports. This was a breach of the Guidelines. Dr Athour admits that he did not refer any of the patients for a psychosocial assessment and admits that he breached the ROD Guidelines. (Particulars 17 and 18). Dr Athour failed to obtain informed consent from any of the patients in relation to undergoing rapid opioid detoxification by failing to and/or record the following: (a)provide a careful explanation of what is involved including the risks; (b)advise the patient that use of Naltrexone in detoxification is off indication; (c) provide the patient with written information regarding the treatment; (d) discuss alternative treatment options; (e)obtain signed consent from the patient. This was a breach of the ROD Guidelines, the NSW Code of Conduct in respect of one of the patients and a breach of the National Code of Conduct in respect of the rest of the patients. Dr Athour admits the Particular except that he denies that he failed to (a) explain to patients what was involved in rapid opioid detoxification including the risks and (d) discuss alternative treatment options. Dr Athour admits he breached the ROD Guidelines and Codes of Conduct. (Particulars 19 and 20). Dr Athour failed to provide adequate psychological counselling and psychosocial support to each of the patients following their procedures. Dr Athour admits this Particular. (Particular 21) 5
7 . Dr Athour failed to provide adequate follow-up care including post-withdrawal management options to all of the patients following their procedures. Dr Athour admits this Particular. (Particular 22). Dr Athour failed to make and/or maintain adequate clinical records for all of the patients with respect to: (a) medical and psychiatric history (b)drug and alcohol use history (c) medical assessment (d)psychological and psychosocial assessment (e)any clinical opinion reached by the practitioner (f) plan of treatment (g)nature of treatment. This contravened the relevant Regulations and Codes of Conduct. Dr Athour admits these Particulars. (Particulars 23 and 24). Dr Athour failed to make any record in his clinical notes for consultations where a Medicare claim was processed, as follows: (a)consultations on 11 July 2010, 20 May 2011, 31 May 2011, 7 June 2011 and 21 June 2011 in respect of Patient K (b)consultations on 31 July 2010 and 1 August 2010 in respect of Patient L. (C) consultation on 6 August 2010 in respect of Patient M. That conduct contravened the HPR Regulation and the National Code of Conduct. Dr Athour denied these Particulars (Particulars 25 and 26). Dr Athour failed to obtain approval under the Special Access Scheme (SAS) in accordance with s19 of the Therapeutic Goods Act 1989 (Commonwealth) to use Naltrexone implants in the treatment of all of the patients. Dr Athour admits this Particular. (Particular 27)
8 Dr Athour inappropriately prescribed MS Contin without the proper authority to drug dependent persons, contrary to s 28(3) of the Poisons and Therapeutic Goods Act 2008 (NSW) on five occasions. Dr Athour admits this Particular. (Particular 28) Resolving the Particulars which are denied by Dr Athour It is common ground that the onus of proof on the balance of probabilities is on the Health Care Complaints Commission. However in making factual findings the Tribunal has had regard to the following: "The seriousness of the allegation made, the inherent unlikelihood of an occurrence of a given description, or the gravity of the consequences flowing from a particular finding are considerations which must affect the answer to the question whether the issue has been provided to the reasonable satisfaction of the Tribunal". Briginshaw v Briginshaw (1938) 60 CLR at 362. Particular 1 There is an issue as to the date on which Patient L underwent rapid opioid detoxification. Dr Athour said it occurred on 28 July 2010 (his first statement), 31 July 2010 (his cross examination) and I August 2010 (his second statement). In circumstances where the Complaint says "on or about July 2010" the Tribunal finds Particular 1 has been proven. Particulars 12 and 13 Dr Athour does not fully admit that he failed to adequately medically assess each of the patients for contraindications to rapid opioid detoxification including: (a) cardiac disease; (b)chronic renal impairment; (c) decompensated liver disease; (d)current dependence on benzodiazepines, alcohol or stimulants; (e)history of psychosis; In relation to (a) cardiac disease, Dr Athour agrees he failed to require any of the patients to undergo an ECG which was necessary to make an adequate medical assessment. 7
9 In relation to investigating whether the patients had (b) renal impairment or (c) decompensated liver disease, Dr Athour concedes that an adequate medical assessment required a blood test and says that this was done in relation to Patients G and J. He concedes that he failed to adequately medically assess the other patients in relation to these conditions. The Tribunal finds that Dr Athour did adequately medically assess those two patients in respect of those two conditions. In relation to (d) current dependence on benzodiazepine, alcohol and stimulants, Dr Athour admits that he did not make an adequate assessment in relation to benzodiazepines. Dr Athour does not admit that he did not make an adequate assessment of the patients current dependence on alcohol or stimulants. Counsel for Dr Athour referred to the medical records of Patient H. The history taken five days before the procedure includes "Currently using heroin I gram iv. Has been using six month. Denies using any other drugs. Smokes IO/d Etoh Nil" which was a reference to alcohol being nil. Counsel for the Health Care Complaints Commission did not refer to the individual records of the 14 patients. It was his submission that asking each patient was not sufficient - Dr Athour should have attempted to verify the information he was given by each patient. The Tribunal is satisfied that the taking of the history from the patient in relation to alcohol and stimulants is an adequate assessment. Dr Athour says that he did adequately medically assess each of the patients in relation to (e) history of psychosis. He asked the patients whether they had any psychological or psychiatric history, any admissions to a hospital for the treatment of psychiatric issues and/or any history of depression or schizophrenia. There is no evidence from any of the patients before the Tribunal. In relation to (e), counsel for the Health Care Complaints Commission submitted that Dr Athour should have sought to verify the history he was given by speaking to any other treating practitioner. This submission was not supported by references to the records of any patient showing that Dr Athour was informed of the identity of other treating practitioners. The Tribunal is not satisfied that the Health Care Complaints Commission has established any of the Particulars which were not admitted by Dr Athour. []
10 Particular 15 Dr Athour admits that he did not refer any of the patients for a psychological assessment before administering rapid opioid detoxification. He says that he conducted the psychological assessment of each patient himself by asking each patient whether they had any psychological or psychiatric history, whether they had had any admissions to hospital for psychiatric issues and whether they had a history of depression or schizophrenia. The Tribunal finds that this does not amount to an adequate psychological assessment which is required before undertaking rapid opioid detoxification. Dr Athour does not have any qualifications in psychology or psychiatry nor did he give evidence of having any particular expertise in conducting psychological assessments. He did not use any written document or any standard test. As discussed further below, in 2008 Dr Athour worked at Psych n Soul (a drug and alcohol treatment centre) performing rapid opioid detoxification where the two hour assessment was undertaken by a psychologist. The whole assessment, including the questions about these issues, undertaken by Dr Athour took 20 minutes. The potential risks to a patient suffering from a significant psychiatric disorder are discussed further below. The Tribunal finds that Particular 15 has been proven. Particular 19 Dr Athour denies that he failed to obtain informed consent from any of the patients in relation to undergoing rapid opioid detoxification by failing to record and/or: (a) provide a careful explanation of what is involved including the risks; (d) discuss alternative treatment options. Dr Athour did give evidence of some of the risks discussed with the patients. However the Tribunal is satisfied that Dr Athour did not appreciate all of the risks attached to performing the procedure at a person s home and could not have explained them to the patients nor obtain their informed consent to those risks. In relation to alternative treatment options, Dr Athour said he asked the patients why they wanted to undergo rapid opioid detoxification. Usually they told him they wanted to go overseas and did not want to be using drugs, or they were dissatisfied with spending years on the Methadone program being unable to work or they did not want to attend each day or second day at a clinic or
11 pharmacy to obtain their Methadone dose or they wanted a rapid solution to their drug use. There is no evidence of a detailed discussion of the advantages and disadvantages of all of the alternative treatment options It is common ground that Dr Athour did not record any of these matters in the patients notes. The Tribunal finds that Particular 19 has been proven. Particulars 25 and 26 Dr Athour says that he did make a record in his clinical notes in relation to each of the consultations detailed in Particular 25. Counsel for the Health Care Complaints Commission conceded that there was an entry in the computer records of the Plus 1 Medical Centre (where Dr Athour was working at the time) for most of the dates. In relation to the other dates, the Tribunal is satisfied that there is a written document and that the written documents are a record in the relevant clinical notes. The Tribunal finds that these Particulars have not been proven. Factual Findings In addition to the findings set out above, the Tribunal finds that the Health Care Complaints Commission has established those Particulars which have been admitted by Dr Athour. Risks Dr Athour was born in Turkey and is 56 years of age. In 1987 he graduated in Germany with an MBBS. He worked in Europe until he migrated to Australia in In 1996 Dr Athour obtained registration as a medical practitioner in New South Wales. Dr Athour is not vocationally registered. He has worked in various positions as a general practitioner In 2007 Dr Athour commenced working at the Plus I Medical Centre which is a general practice. He saw the 14 patients at this practice before he undertook each of their procedures. 10
12 In 2007 Dr Athour also commenced working at the Barbara Street Clinic, which is an Opioid Substitution Clinic. He exclusively works with pharmacotherapy patients requiring initiation or maintenance on methadone or buprenorphine. Dr Athour s training and experience in addiction medicine, at the time he performed the procedures the subject of this Complaint, was the following: attending a one day Methadone Prescribers course in 2003 at Westmead Hospital. As has already been noted, in 2008 Dr Athour worked at Psych n Soul for 4 months performing rapid opioid detoxification one day a week. He was trained by Dr Tan whom he was replacing at the practice. The patients had been assessed by others as being suitable to undergo the procedure. Dr Athour only undertook the final medical assessment and then performed the procedure on three patients a day. Dr Tan explained the procedure to him, he observed Dr Tan performing a number of procedures and Dr Tan observed him performing procedures. He cannot remember being told about or shown any policy or procedure manuals. Relevantly for these proceedings Dr Athour says that Dr Tan told him that patients undergoing rapid opioid detoxification were required to be abstinent from drugs for a period of 12 hours before the procedure, rather than the 48 hours required by the Guidelines. In addition Dr Tan used Naltrexone implants so he had assumed the implants had been approved for use. The Tribunal is satisfied that Dr Athour s conduct raises the following concerns: There is no evidence of Dr Athour taking any meaningful steps to ensure that he had any real understanding of the rapid opioid detoxification procedure and the risks associated with undertaking the procedure. Professor Saunders has given evidence, which we accept, that there would have been a lot of information available to Dr Athour both in the professional literature and in government guidelines. There was a real risk of serious and potentially fatal complications so that the practice of carrying out the procedure in a family home or hotel room was inappropriate and dangerous. As Dr Athour concedes the procedure should be done in an environment where there is access to basic resuscitation equipment and the capacity for the patient to remain in inpatient care overnight. In addition, after Dr Athour left, there was no qualified person monitoring the progress of each of the patients. This would include taking the patient s pulse, blood pressure and respiratory rate and using the opioid withdrawal rating scales. 11
13 There was also the risk of distress to that family member at seeing the symptoms experienced by the patient. Dr Athour failed to ensure that each of the patients had been opioid free for at least 48 hours prior to initiating rapid opioid detoxification. Professor Saunders said that the severity of the withdrawal syndrome would be less if the person had been opiold free for at least 48 hours. The Guidelines state "Failure to observe these intervals can lead to severe withdrawal reactions and other serious complications. It is not acceptable to compromise safety in the hope of a good outcome." Dr Athour did take a short history from at least some of the patients before the procedure. He said he spent 20 minutes with each patient. The Guidelines set out best practice for a comprehensive assessment. It is clear that Dr Athour s usual practice fell well short of these requirements. In addition to the matters already discussed he did not develop a treatment plan. He did not take a sufficient history to exclude those patients for whom rapid opioid detoxification was contraindicated - for example his failure to undertake an adequate psychological assessment and past psychiatric assessment meant that he could not exclude a patient with a significant psychiatric history. Such patients were not appropriate candidates for rapid opiold detoxification because in the detoxification process some patients become very anxious and very depressed. They may also become depressed as a result of Naltrexone treatment. That risk should not be imposed on a person who has a history of depression, bipolar disorder or other significant psychiatric disorder. Dr Athour provided rapid opioid detoxification to a patient with epilepsy without undertaking research regarding the safety of the procedure in epileptic patients and he did not seek advice regarding the safety of rapid opiold detoxification in epileptic patients from specialists in the area of addiction medicine. Professor Saunders expressed concerns about the procedure being administered on a patient with a history of epilepsy. Dr Athour admits that he did not refer any of the patients for a psychosocial assessment before undertaking the procedure. The Guidelines provide that a relative contraindication for rapid oploid detoxification is unstable social circumstances. The Guidelines state that a patient who is homeless or in highly unstable social circumstances requires a comprehensive plan to stabilise his or her circumstances before the procedure is undertaken. 12
14 Dr Athour failed to provide adequate follow-up care including post-withdrawal management options to all of the patients following their procedures. The Guidelines provide that vigorous attempts to follow patients are indicated after rapid opioid detoxification. Generally patients should be seen daily for three days then at weekly intervals. The aftercare should include medical monitoring and counselling. None of the patients were provided with this level of care. Dr Athour s inexperience and lack of training meant that he was unaware that he needed to obtain approval under the Special Access Scheme to use Naltrexone implants in the treatment of all of the patients. Dr Athour s inexperience and lack of training meant that he inappropriately prescribed MS Contin without the proper authority to drug dependent persons on five occasions. Unsatisfactory professional conduct Dr Athour admits that he is guilty of unsatisfactory professional conduct. The Health Care Complaints Commission says that Dr Athour is guilty of unsatisfactory professional conduct under s 139B (1) (a), (b), (c) and (I) of the National Law in that he has engaged in conduct that demonstrates that the knowledge, skill or judgement possessed, or care exercised, by him in the practice of medicine is significantly below the standard reasonably expected of a practitioner of an equivalent level of training or experience. The Health Care Complaints Commission did not press the final ground - that Dr Athour engaged in improper or unethical conduct relating to the practice or purported practice of medicine. The Tribunal has made findings as to the conduct of Dr Athour, the errors in his skills, judgement and care which are demonstrated by that conduct and the significant risks to the health and safety of the patients that were created by his conduct. The Tribunal is satisfied that Dr Athour engaged in conduct which demonstrated that his knowledge and judgement in the practice of medicine was significantly below the standard reasonably expected of a practitioner of an equivalent level of training or experience. The Tribunal finds that Dr Athour is guilty of unsatisfactory professional conduct. 13
15 Professional misconduct Dr Athour admits that he is guilty of professional misconduct. The Health Care Complaints Commission says that Dr Athour is guilty of professional misconduct under section 139E of the National Law in that h practitioner has: (i) engaged in unsatisfactory professional conduct of a sufficiently serious nature to justify suspension or cancellation of the practitioner s registration; and/or (j) engaged in more than one instance of unsatisfactory professional conduct that, when the instances are considered together, amount to conduct of a sufficiently serious nature to justify suspension or cancellation of the practitioner s registration. The Tribunal is satisfied that Dr Athour engaged in more than one instance of unsatisfactory professional conduct that, when the instances are considered together, amount to conduct of a sufficiently serious nature to justify suspension or cancellation of his registration. The Tribunal finds that Dr Athour s conduct amounts to professional misconduct. 14
16 Medical Tribunal of New South Wales Health Care Complaints Commission and Dr Zeitoun Athour Matter No: of 2012 Dr Esther Kok Member Dr Glenys Dore Member ~9T -C- Dr A Glass, PhD Member A Balla DCJ. Deputy Chair
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently Asked Questions What is Naltrexone? Naltrexone is a prescription drug that effectively blocks the effects of heroin, alcohol,
More informationDEVELOPING MANUFACTURING SUPPLYING. Naltrexone Implants. Manufactured by NalPharm Ltd WWW.NALPHARM.COM
DEVELOPING MANUFACTURING SUPPLYING Naltrexone Implants Background to Nalpharm NalPharm is a specialist pharmaceutical company supplying proprietary branded medications and generic drugs in the area of
More informationWe are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.
Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Borough of Poole - Civic Centre Borough of Poole, Civic Centre,
More informationRULES OF THE TENNESSEE DEPARTMENT OF MENTAL HEALTH AND DEVELOPMENTAL DISABILITIES
RULES OF THE TENNESSEE DEPARTMENT OF MENTAL HEALTH AND DEVELOPMENTAL DISABILITIES CHAPTER 0940-05-47 MINIMUM PROGRAM REQUIREMENTS FOR ALCOHOL AND DRUG OUTPATIENT DETOXIFICATION TREATMENT FACILITIES TABLE
More informationCare Management Council submission date: August 2013. Contact Information
Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing
More information1. According to recent US national estimates, which of the following substances is associated
1 Chapter 36. Substance-Related, Self-Assessment Questions 1. According to recent US national estimates, which of the following substances is associated with the highest incidence of new drug initiates
More informationTHE BASICS. Community Based Medically Assisted Alcohol Withdrawal. World Health Organisation 2011. The Issues 5/18/2011. RCGP Conference May 2011
RCGP Conference May 2011 Community Based Medically Assisted Alcohol Withdrawal THE BASICS An option for consideration World Health Organisation 2011 Alcohol is the world s third largest risk factor for
More informationFrequently asked questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently asked questions What is Naltrexone? Naltrexone is a prescription drug that completely blocks the effects of all opioid drugs
More informationSCOTTISH PRISON SERVICE DRUG MISUSE AND DEPENDENCE OPERATIONAL GUIDANCE
SCOTTISH PRISON SERVICE DRUG MISUSE AND DEPENDENCE OPERATIONAL GUIDANCE 1 P a g e The following Operational Guidance Manual has been prepared with input from both community and prison addictions specialists
More informationNew York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery
New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery USING THE 48 HOUR OBSERVATION BED USING THE 48 HOUR OBSERVATION BED Detoxification
More informationRapid Opioid Detoxification - Guidelines
Guideline Rapid Opioid Detoxification - Guidelines Document Number GL2011_009 Publication date 21-Jul-2011 Functional Sub group Clinical/ Patient Services - Medical Treatment Department of Health, NSW
More informationGUIDELINES FOR COMMUNITY ALCOHOL DETOXIFICATION IN SHARED CARE
GUIDELINES FOR COMMUNITY ALCOHOL DETOXIFICATION IN SHARED CARE Dr Millicent Chikoore MBBS MRCPsych Dr O Lagundoye MBBS MRCPsych Community based alcohol detoxification is a safe and effective option for
More informationSUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D]
SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D] I. Definitions: Detoxification is the process of interrupting the momentum of compulsive drug and/or alcohol use in an individual
More informationADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines - 2015
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
More informationAdjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour.
Shared Care Guideline for Prescription and monitoring of Naltrexone Hydrochloride in alcohol dependence Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist,
More informationA G U I D E F O R U S E R S N a l t r e x o n e U
A GUIDE FOR USERS UNaltrexone abstinence not using a particular drug; being drug-free. opioid antagonist a drug which blocks the effects of opioid drugs. dependence the drug has become central to a person
More informationOhio Legislative Service Commission
Ohio Legislative Service Commission Bill Analysis Brian D. Malachowsky H.B. 378 130th General Assembly () Reps. Smith and Sprague BILL SUMMARY Prohibits a physician from prescribing or personally furnishing
More informationNaltrexone and Alcoholism Treatment Test
Naltrexone and Alcoholism Treatment Test Following your reading of the course material found in TIP No. 28. Please read the following statements and indicate the correct answer on the answer sheet. A score
More informationUpdate and Review of Medication Assisted Treatments
Update and Review of Medication Assisted Treatments for Opiate and Alcohol Use Disorders Richard N. Whitney, MD Medical Director Addiction Services Shepherd Hill Newark, Ohio Medication Assisted Treatment
More informationTREATMENT MODALITIES. May, 2013
TREATMENT MODALITIES May, 2013 Treatment Modalities New York State Office of Alcoholism and Substance Abuse Services (NYS OASAS) regulates the addiction treatment modalities offered in New York State.
More informationSPECIFICATION FOR THE LOCAL COMMISSIONED SERVICE FOR THE MANAGEMENT ALCOHOL MISUSE
SPECIFICATION FOR THE LOCAL COMMISSIONED SERVICE FOR THE MANAGEMENT OF ALCOHOL MISUSE Date: March 2015 1 1. Introduction Alcohol misuse is a major public health problem in Camden with high rates of hospital
More informationFile No 00/1287 Circular No 2001/17. Issued 23 February 2001. Contact. Guidelines for Rapid Detoxification from Opioids
CIRCULAR File No 00/1287 Circular No 2001/17 Issued 23 February 2001 Contact Anthony Jackson (02) 9391 9538 Drug Programs Bureau Guidelines for Rapid Detoxification from Opioids This Circular should be
More informationKENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE
KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE 201 KAR 9:260. Professional standards for prescribing and dispensing controlled substances.
More informationDRUG AND ALCOHOL DETOXIFICATION: A GUIDE TO OUR SERVICES
01736 850006 www.bosencefarm.co.uk DRUG AND ALCOHOL DETOXIFICATION: A GUIDE TO OUR SERVICES An environment for change Boswyns provides medically-led drug and alcohol assessment, detoxification and stabilisation.
More informationGuidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care
Hull & East Riding Prescribing Committee Guidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care 1. BACKGROUND Patients who are physically dependent
More informationHealth Care Complaints Commission. Complainant. Karanalu Vinatheya Prakash. Respondent. Dr E Kok Ms A Deveson JUDGMENT.
Health Care Complaints Commission Complainant Karanalu Vinatheya Prakash Respondent Deputy Chair: Members: Judge A M Ainslie-Wallace Dr M Pasfield Dr E Kok Ms A Deveson JUDGMENT Introduction: This is an
More informationWhat Is Medically. Supervised Detoxification? Chapter 13
Chapter 13 What Is Medically Supervised Detoxification? T I have been a heroin addict for three years and am desperately trying to stop. As the withdrawal symptoms are very severe, the muscle cramps, shakes,
More information75-09.1-08-02. Program criteria. A social detoxi cation program must provide:
CHAPTER 75-09.1-08 SOCIAL DETOXIFICATION ASAM LEVEL III.2-D Section 75-09.1-08-01 De nitions 75-09.1-08-02 Program Criteria 75-09.1-08-03 Provider Criteria 75-09.1-08-04 Admission and Continued Stay Criteria
More informationInformation for Pharmacists
Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl
More informationLegal Services Commissioner L.G. Yves Michel Melbourne Vice President Judge I J K Ross Hearing
VICTORIAN CIVIL AND ADMINISTRATIVE TRIBUNAL CIVIL DIVISION LEGAL PRACTICE LIST VCAT REFERENCE NO. J33 & J57 OF 2009 CATCHWORDS Legal Profession Act 2004 s 4.4.11(1)(b) failure to provide documents and
More informationPrescription Drug Abuse
Prescription Drug Abuse Introduction Most people take medicines only for the reasons their health care providers prescribe them. But millions of people around the world have used prescription drugs for
More informationCOMMUNITY BUPRENORPHINE PRESCRIBING IN OPIATE DEPENDENCE
COMMUNITY BUPRENORPHINE PRESCRIBING IN OPIATE DEPENDENCE INTRODUCTION High dose sublingual buprenorphine (Subutex) tablets are available in the following strengths 0.4 mg, 2 mg, and 8 mg. Suboxone tablets,
More informationOpioid Treatment Services, Office-Based Opioid Treatment
Optum 1 By United Behavioral Health U.S. Behavioral Health Plan, California Doing Business as OptumHealth Behavioral Solutions of California ( OHBS-CA ) 2015 Level of Care Guidelines Opioid Treatment Services,
More informationmethadonefact.qxd 8/11/01 2:05 PM Page 1 INFORMATION Advantages of methadone treatment DEPRESSANT Methadone maintenance Pregnancy METHADONE
methadonefact.qxd 8/11/01 2:05 PM Page 1 INFORMATION Advantages of methadone treatment 10 DEPRESSANT Methadone maintenance Pregnancy METHADONE methadonefact.qxd 8/11/01 2:05 PM Page 2 WHAT IS METHADONE
More informationYOU CAN BE OF SUPPORT TO THE ADDICTED PERSON IN RECOVERY
YOU CAN BE OF SUPPORT TO THE ADDICTED PERSON IN RECOVERY Addiction is a disease which leads to physical and emotional problems. It also causes problems in almost all areas of life. The drug dependents
More informationElectroconvulsive Therapy - ECT
Electroconvulsive Therapy - ECT Introduction Electroconvulsive therapy, or ECT, is a safe and effective treatment that may reduce symptoms related to depression or mental illness. During ECT, certain parts
More informationMaintenance of abstinence in alcohol dependence
Shared Care Guideline for Prescription and monitoring of Acamprosate Calcium Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist, Alcohol Services Dr Donnelly
More informationPatients are still addicted Buprenorphine is simply a substitute for heroin or
BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module VI: Myths About the Use of Medication in Recovery Patients are still addicted Buprenorphine is simply a substitute
More informationAntipsychotic drug prescription for patients with dementia in long-term care. A practice guideline for physicians and caregivers
SUPPLEMENT 1: (Supplementary Material for online publication) Antipsychotic drug prescription for patients with dementia in long-term care. A practice guideline for physicians and caregivers About this
More informationUse of Buprenorphine in the Treatment of Opioid Addiction
Use of Buprenorphine in the Treatment of Opioid Addiction Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Executive Summary Which of the following is an
More informationTriage, Assessment & Treatment Methadone 101/Hospitalist Workshop
Triage, Assessment & Treatment Methadone 101/Hospitalist Workshop Launette Rieb, MSc, MD, CCFP, FCFP Clinical Associate Professor, Dept. Family Practice UBC American Board of Addiction Medicine Certified
More informationINTOXICATED PATIENTS AND DETOXIFICATION
VAMC Detoxification Decision Tree Updated May 2006 INTOXICATED PATIENTS AND DETOXIFICATION Patients often present for evaluation of substance use and possible detoxification. There are certain decisions
More informationProvider enews TREATING PRESCRIPTION DRUG ADDICTION
Provider enews TREATING PRESCRIPTION DRUG ADDICTION Treating addiction to prescription opioids July 2012 Several options are available for effectively treating prescription opioid addiction. These options
More informationWorking with young people who have mental health and substance use issues. Samar Zakaria
Working with young people who have mental health and substance use issues. Samar Zakaria Main points Challenges faced while treating young adults in a dual diagnosis rehab unit Define dual diagnosis in
More informationConsiderations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT
Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA
More informationAlcohol. Problems with drinking alcohol
Alcohol Alcoholism is a word which many people use to mean alcohol dependence (alcohol addiction). Some people are problem drinkers without being dependent on alcohol. If you are alcohol- dependent then
More informationMichael Brennan, MA, LMHC Providence St. Peter Hospital Crisis Services
Michael Brennan, MA, LMHC Providence St. Peter Hospital Crisis Services Welcome to the E.R.: Emergency: noun Webster 1. a sudden, urgent, usually unexpected occurrence or occasion requiring immediate action.
More informationNHS FORTH VALLEY. Guidance on Alcohol Dependence: Maintenance of Abstinence. Contact: Valerie Kippen Area Drug & Therapeutics Committee
NHS FORTH VALLEY Guidance on Alcohol Dependence: Maintenance of Abstinence Approved 06/09/2012 Version 5.0 Date of First Issue February 2008 Review Date 06/09/2014 Current Issue Date 26/11/2012 EQIA Yes
More informationOVERVIEW WHAT IS POLyDRUG USE? Different examples of polydrug use
Petrol, paint and other Polydrug inhalants use 237 11 Polydrug use Overview What is polydrug use? Reasons for polydrug use What are the harms of polydrug use? How to assess a person who uses several drugs
More informationMEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Mark Fisher Program Administrator State Opioid Treatment Adminstrator Kentucky Division of Behavioral Health OBJECTIVES Learn about types of opioids and
More informationMEDICAL ASSISTANCE BULLETIN
ISSUE DATE September 4, 2015 SUBJECT EFFECTIVE DATE September 9, 2015 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments, Oral Buprenorphine Agents - Pharmacy
More informationEPIDEMIOLOGY OF OPIATE USE
Opiate Dependence EPIDEMIOLOGY OF OPIATE USE Difficult to estimate true extent of opiate dependence Based on National Survey of Health and Mental Well Being: 1.2% sample used opiates in last 12 months
More informationRULES OF THE TENNESSEE DEPARTMENT OF MENTAL HEALTH AND DEVELOPMENTAL DISABILITIES
RULES OF THE TENNESSEE DEPARTMENT OF MENTAL HEALTH AND DEVELOPMENTAL DISABILITIES CHAPTER 0940-05-44 MINIMUM PROGRAM REQUIREMENTS FOR ALCOHOL AND DRUG RESIDENTIAL DETOXIFICATION TREATMENT FACILITIES TABLE
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: PDP IBT Inj - Vivitrol Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Opiate Antagonist Client: 2007 PDP IBT Inj Approval Date: 2/20/2007
More informationOxford Health NHS Foundation Trust. A guide to Opioid Detoxification
Oxford Health NHS Foundation Trust A guide to Opioid Detoxification If you re considering detox, congratulations. You have obviously been visualising a drug free life and planning your future goals. Detox
More informationMethadone treatment Information for service users Page
South London and Maudsley NHS Foundation Trust Methadone treatment Information for service users Page What can happen if I stop using heroin? If you are addicted to or dependent on heroin, you develop
More informationMental Health Services
Mental Health Services At Maitland Private Hospital our team of professionals are committed to providing comprehensive assessment, treatment and support of people experiencing mental health issues. Located
More informationWitness Protection Act 1995 No 87
New South Wales Witness Protection Act 1995 No 87 Status information Currency of version Current version for 5 October 2012 to date (generated 10 October 2012 at 19:15). Legislation on the NSW legislation
More informationAppendix D. Behavioral Health Partnership. Adolescent/Adult Substance Abuse Guidelines
Appendix D Behavioral Health Partnership Adolescent/Adult Substance Abuse Guidelines Handbook for Providers 92 ASAM CRITERIA The CT BHP utilizes the ASAM PPC-2R criteria for rendering decisions regarding
More informationGP Drug & Alcohol Supplement No.7 May 1997
GP Drug & Alcohol Supplement No.7 May 1997 This is the seventh of the monthly Drug and Alcohol Supplements prepared for Central Coast GPs. Detoxification from Alcohol Dr Tony Gill Introduction The management
More informationHAWAII BOARD OF MEDICAL EXAMINERS PAIN MANAGEMENT GUIDELINES
Pursuant to section 453-1.5, Hawaii Revised Statutes, the Board of Medical Examiners ("Board") has established guidelines for physicians with respect to the care and treatment of patients with severe acute
More informationIN THE LEGAL PRACTITIONERS DISCIPLINARY TRIBUNAL ACTION NO. 9 OF 2012 IN THE MATTER OF: THE LEGAL PRACTITIONERS ACT 1981. and IN THE MATTER OF:
IN THE LEGAL PRACTITIONERS DISCIPLINARY TRIBUNAL ACTION NO. 9 OF 2012 IN THE MATTER OF: THE LEGAL PRACTITIONERS ACT 1981 and IN THE MATTER OF: VICTOR KUDRA 1. The Practitioner is charged with unprofessional
More informationAlcohol-use disorders
Issue date: February 2011 Alcohol-use disorders Diagnosis, assessment and management of harmful drinking and alcohol dependence Alcohol dependence: NICE guideline FINAL DRAFT (February 2011) 1 NICE clinical
More informationGuidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998
Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Section I: Preamble The New Hampshire Medical Society believes that principles
More informationTENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION
TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION The Tennessee Board of Medical Examiners has reviewed the Model Policy Guidelines for Opioid Addiction Treatment
More informationAMA NSW AND ASMOF NSW Submission on Health Practitioners Regulation National Law
AMA NSW AND ASMOF NSW Submission on Health Practitioners Regulation National Law This submission is filed jointly on behalf of AMA NSW and ASMOF NSW. We note the submission of the Australian Medical Association
More informationTreatment of Alcoholism
Treatment of Alcoholism Why is it important Prevents further to body by getting people off alcohol. Can prevent death. Helps keep health insurance down. Provides assistance so alcoholics don t t have to
More informationFRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma
FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma Background A growing opiate abuse epidemic has highlighted the need for effective treatment options. This study documents
More informationSupervision on the borderline of health and social care. Nordic Supervisory Conference Helsinki 1.-2. oktober 2015
Nordic Supervisory Conference Helsinki 1.-2. oktober 2015 Parallel supervisory visits in Denmark Treatment areas with supervisory visits from the Danish health and medicines authority and the Danish social
More informationa five-day medically supervised residential detoxification programme
Substance PICU and Acute Misuse and Services Detox Services Psychiatric Cygnet Hospital Intensive Harrogate Care and Acute services a five-day medically supervised residential detoxification programme
More informationPUBLIC RECORD. Record of Determinations Fitness to Practise Panel. Dates 07 May 2015-08 May 2015. Medical Practitioner. Dr John Stanley Partington
PUBLIC RECORD Dates 07 May 2015-08 May 2015 Name of Medical Practitioner Dr John Stanley Partington Primary medical qualification MB BS 1987 University of Newcastle upon Tyne GMC reference number 3184336
More informationadaptations whenever possible, to prevent or reduce the occurrence of challenging behaviours.
POSITION STATEMENT on Management of Challenging Behaviours in People with Dementia 1. AIM OF THE POSITION STATEMENT This position statement applies to people living in supported accommodation and those
More informationTreatments for drug misuse
Understanding NICE guidance Information for people who use NHS services Treatments for drug misuse NICE clinical guidelines advise the NHS on caring for people with specific conditions or diseases and
More informationHow To Treat A Drug Addiction
1 About drugs Drugs are substances that change a person s physical or mental state. The vast majority of drugs are used to treat medical conditions, both physical and mental. Some, however, are used outside
More informationTHE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES
THE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES PURPOSE: The goal of this document is to describe the
More informationCorl Kerry - Referral and Assessment for Residential Treatment (Tier 4) Introduction Types of Tier 4 Services Services provided at Tier 4
Corl Kerry - Referral and Assessment for Residential Treatment (Tier 4) This document seeks to name the criteria that can guide referrals to residential tier 4 facilities (Part A). It provides guidance
More informationBehavioral Health Medical Necessity Criteria
Behavioral Health Medical Necessity Criteria Revised: 7/14/05 2 nd Revision: 9/14/06 3 rd Revision: 8/23/07 4 th Revision: 8/28/08; 11/20/08 5 th Revision: 8/27/09 Anthem Blue Cross and Blue Shield 2 Gannett
More information02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION
Effective June 13, 2010 02-313, 02-373, 02-380, 02-383, 02-396 Chapter 21 page 1 02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 313 BOARD OF DENTAL EXAMINERS 373 BOARD OF LICENSURE IN MEDICINE
More informationGuidelines on endorsement as a nurse practitioner
Guidelines on endorsement as a nurse practitioner 7160 Introduction The National Registration and Accreditation Scheme (the National Scheme) for health professionals in Australia commenced on 1 July 2010
More informationDR ANTHONY C CUMMING B.A. (Hons.), B.D., Grad. Dip. Ed. (Rel. Ed.), M.Psych. (Clin.), M. Crim. (Foren. Psych.), Ph.D., M.A.P.S
DR ANTHONY C CUMMING B.A. (Hons.), B.D., Grad. Dip. Ed. (Rel. Ed.), M.Psych. (Clin.), M. Crim. (Foren. Psych.), Ph.D., M.A.P.S CLINICAL PSYCHOLOGIST Member The Australian Psychological Society College
More informationACUTE TREATMENT SERVICES (ATS) FOR SUBSTANCE USE DISORDERS LEVEL III.7
ACUTE TREATMENT SERVICES (ATS) FOR SUBSTANCE USE DISORDERS LEVEL III.7 Providers contracted for this level of care or service are expected to comply with all requirements of these service-specific performance
More informationThe Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office
The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office Adopted April 2013 for Consideration by State Medical Boards 2002 FSMB Model Guidelines
More informationObjectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons.
Addiction Psychiatry Program Site Specific Goals and Objectives Addiction Psychiatry (ADTU) Goal: By the end of the rotation fellow will acquire the knowledge, skills and attitudes required to recognize
More informationBuprenorphine: what is it & why use it?
Buprenorphine: what is it & why use it? Dr Nicholas Lintzeris, MBBS, PhD, FAChAM Locum Consultant, Oaks Resource Centre, SLAM National Addiction Centre, Institute of Psychiatry Overview of presentation
More informationORDER OF EMERGENCY SUSPENSION OF LICENSE
Final Order No. DOH-I -2295- QA FILED DATE -R AA Department of Health STATE OF FLORIDA DEPARTMENT OF HEALTH In Re: Emergency Suspension of the License of By Deputy Agency Clerk ORDER OF EMERGENCY SUSPENSION
More informationBenzodiazepine Detoxification and Reduction of Long term Use
Benzodiazepine Detoxification and Reduction of Long term Use Malcolm Lader 1 Model of general drug misuse and dependence. Tactical interventional options Social dimension Increasing breaking of social
More information3.1 TWELVE CORE FUNCTIONS OF THE CERTIFIED COUNSELLOR
3.1 TWELVE CORE FUNCTIONS OF THE CERTIFIED COUNSELLOR The Case Presentation Method is based on the Twelve Core Functions. Scores on the CPM are based on the for each core function. The counsellor must
More informationCongressional Testimony. Laurence M. Westreich, M.D. President, American Academy of Addiction Psychiatry
Congressional Testimony Laurence M. Westreich, M.D. President, American Academy of Addiction Psychiatry Combatting the Opioid Abuse Epidemic: Professional and Academic Perspectives, April 23 rd 2015 Subcommittee
More informationTreatment of opioid use disorders
Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence
More informationThese changes are prominent in individuals with severe disorders, but also occur at the mild or moderate level.
Substance-Related Disorders DSM-V Many people use words like alcoholism, drug dependence and addiction as general descriptive terms without a clear understanding of their meaning. What does it really mean
More informationAmerican Society of Addiction Medicine
American Society of Addiction Medicine Public Policy Statement on Treatment for Alcohol and Other Drug Addiction 1 I. General Definitions of Addiction Treatment Addiction Treatment is the use of any planned,
More informationCo-morbid physical disorders e.g. HIV, hepatitis C, diabetes, hypertension. Medical students will gain knowledge in
1.0 Introduction Medications are used in the treatment of drug, alcohol and nicotine dependence to manage withdrawal during detoxification, stabilisation and substitution as well as for relapse prevention,
More informationHow To Treat Anorexic Addiction With Medication Assisted Treatment
Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious
More informationTreatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate
More informationA BILL FOR AN ACT ENTITLED: "AN ACT REVISING LAWS RELATING TO GUARDIANSHIP; REVISING
HB0.0 HOUSE BILL NO. INTRODUCED BY J. ESSMANN, M. FUNK A BILL FOR AN ACT ENTITLED: "AN ACT REVISING LAWS RELATING TO GUARDIANSHIP; REVISING LAWS RELATING TO THE COMMITMENT OF INCAPACITATED PERSONS; PROVIDING
More informationMEDICAL ASSISTANCE BULLETIN
ISSUE DATE SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical
More informationCalifornia Society of Addiction Medicine (CSAM) Consumer Q&As
C o n s u m e r Q & A 1 California Society of Addiction Medicine (CSAM) Consumer Q&As Q: Is addiction a disease? A: Addiction is a chronic disorder, like heart disease or diabetes. A chronic disorder is
More informationGetting the best result from Opioid medicine. in the management of chronic pain
Getting the best result from Opioid medicine in the management of chronic pain Your doctor has prescribed you opioid medicine to help you manage your chronic pain. This patient information leaflet gives
More informationMOH CLINICAL PRACTICE GUIDELINES 2/2008 Prescribing of Benzodiazepines
MOH CLINICL PRCTICE GUIELINES 2/2008 Prescribing of Benzodiazepines College of Family Physicians, Singapore cademy of Medicine, Singapore Executive summary of recommendations etails of recommendations
More informationMethadone for Substance Abuse. By: Angela M. Martinez
Methadone for Substance Abuse By: Angela M. Martinez When taken orally once a day, methadone suppresses narcotic withdrawal for between 24 and 36 hours. Because methadone is effective in eliminating withdrawal
More information